We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

215 hedge funds and large institutions have $2.47B invested in Arena Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

60% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 43

31% more capital invested

Capital invested by funds: $1.88B → $2.47B (+$586M)

19% more call options, than puts

Call options by funds: $19.5M | Put options by funds: $16.4M

17% more funds holding

Funds holding: 184 → 215 (+31)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
215
Holders Change
+31
Holders Change %
+16.85%
% of All Funds
4.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
58
Increased
69
Reduced
43
Closed
23
Calls
$19.5M
Puts
$16.4M
Net Calls
+$3.06M
Net Calls Change
-$6.54M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$50.6M
2
N
Nuveen
North Carolina
+$23.4M
3
EMG
ETF Managers Group
New Jersey
+$20.9M
4
Invesco
Invesco
Georgia
+$11.2M
5
MCM
Matarin Capital Management
New York
+$10.7M

Top Sellers

1
PHS
PFM Health Sciences
California
-$73.7M
2
RCMNY
Rubric Capital Management (New York)
New York
-$38.4M
3
Citadel Advisors
Citadel Advisors
Florida
-$16.7M
4
MWNA
Marshall Wace North America
New York
-$16.5M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
51
Allianz Asset Management
Germany
$6.1M +$149K +2,876 +3%
AA
52
ALPS Advisors
Colorado
$6.06M -$824K -15,952 -13%
DCM
53
DAFNA Capital Management
California
$5.51M – – –
CAM
54
ClariVest Asset Management
California
$5.5M +$1.65M +31,900 +52%
Swiss National Bank
55
Swiss National Bank
Switzerland
$5.39M +$98.2K +1,900 +2%
Point72 Asset Management
56
Point72 Asset Management
Connecticut
$5.32M +$4.69M +90,735 New
Arrowstreet Capital
57
Arrowstreet Capital
Massachusetts
$4.74M +$4.18M +80,871 New
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$4.51M +$47.3K +916 +1%
Lord, Abbett & Co
59
Lord, Abbett & Co
New Jersey
$4.5M -$1.81M -35,039 -31%
EP
60
Eversept Partners
New York
$4.31M -$115K -2,220 -3%
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$4.13M +$177K +3,434 +5%
Millennium Management
62
Millennium Management
New York
$3.96M +$3.49M +67,595 New
DekaBank Deutsche Girozentrale
63
DekaBank Deutsche Girozentrale
Germany
$3.85M +$1.33M +25,800 +64%
California Public Employees Retirement System
64
California Public Employees Retirement System
California
$3.75M +$102K +1,977 +3%
QI
65
QS Investors
New York
$3.72M +$1.74M +33,681 +113%
Barclays
66
Barclays
United Kingdom
$3.67M +$1.75M +33,863 +118%
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$3.65M +$571K +11,052 +22%
Rafferty Asset Management
68
Rafferty Asset Management
New York
$3.64M -$470K -9,098 -13%
AL
69
AJO LP
Pennsylvania
$3.54M +$3.12M +60,385 New
CIP
70
Chartwell Investment Partners
Pennsylvania
$3.53M +$186K +3,604 +6%
Neuberger Berman Group
71
Neuberger Berman Group
New York
$3.51M +$2.39M +46,300 +343%
B
72
Bailard
California
$3.46M -$413K -8,000 -12%
Thrivent Financial for Lutherans
73
Thrivent Financial for Lutherans
Minnesota
$3.38M +$38.1K +738 +1%
AQR Capital Management
74
AQR Capital Management
Connecticut
$3.19M +$75.9K +1,468 +3%
Russell Investments Group
75
Russell Investments Group
United Kingdom
$3.16M +$2.79M +54,062 New
1 2
3
4 5

ARNA Hedge Fund Activity: Q2 2019 in Review

215 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2019, worth a combined $2.47B — up 31% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ARNA positions and 23 closed out — a net gain of 35 holders — while 69 added to existing stakes and 43 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $50.6M. The largest seller was PFM Health Sciences, cutting an estimated $73.7M.

  • 215 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2019, up from 184 in Q1 2019.
  • Funds reported $2.47B of Arena Pharmaceuticals Inc stock for Q2 2019, up 31% quarter-over-quarter.
  • 58 funds opened new Arena Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of +35 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2019 was AllianceBernstein, an estimated $50.6M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2019 was PFM Health Sciences, an estimated $73.7M sold.

Based on aggregated 13F filings for Q2 2019.